This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is true about learning disabilities? a. They can rarely be treated ... (Read 48 times)

james9437

  • Hero Member
  • *****
  • Posts: 568
Which of the following is true about learning disabilities?
 
  a. They can rarely be treated successfully.
  b. They are difficult to diagnose because there is a lack of widely used assessment
  criteria and tools.
  c. They are frequently treated through pharmacological means.
  d. Their empirical validity has been clearly established.
  e. Empirical evidence suggests that psychological or family factors are at the origin
  of learning disabilities.

Question 2

Although problem assessment is considered important, DSM-5 diagnosis is generally not the focus of this assessment.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

welcom1000

  • Sr. Member
  • ****
  • Posts: 298
Answer to Question 1

B

Answer to Question 2

True




james9437

  • Member
  • Posts: 568
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


Jossy

  • Member
  • Posts: 336
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library